NEUROONE MEDICAL TECHNOLOGIES Corp
AI Executive Summary
AI-powered analysis of 10-Q filing content
NeuroOne Medical Technologies shows significant financial deterioration with cash declining 57% to $2.8M, net losses increasing 687% to $3.8M for six months, and operating losses expanding 324% to $4.1M. The company faces immediate liquidity concerns despite modest revenue growth.
Red Flags Detected (6)
Cash burn of $3.8M over 6 months with only $2.8M remaining
Operating losses increased 324% to $4.1M vs prior year $1.0M loss
Net loss per share deteriorated from $(0.09) to $(0.45)
3 more red flags detected
Key Takeaways
Revenue grew 2% to $4.8M but operating expenses consumed $6.7M
Gross profit margin remains healthy at 54% but insufficient to cover operating costs
2 more takeaways
Filing Overview
What This Means
High Risk Filing: This company is showing signs of financial stress or significant operational challenges.
Deteriorating Trend: Conditions are worsening compared to previous filings. This may create opportunities for service providers.
Quarterly Report: Interim filing with unaudited financial data for the quarter.